Jason Bednar

Stock Analyst at Piper Sandler

(2.06)
# 3,057
Out of 5,044 analysts
183
Total ratings
37.14%
Success rate
-5.39%
Average return

Stocks Rated by Jason Bednar

ICU Medical
Sep 10, 2025
Maintains: Overweight
Price Target: $145$153
Current: $120.11
Upside: +27.38%
The Cooper Companies
Aug 28, 2025
Maintains: Overweight
Price Target: $105$83
Current: $71.75
Upside: +15.68%
Solventum
Aug 8, 2025
Maintains: Overweight
Price Target: $87$94
Current: $70.92
Upside: +32.54%
Becton, Dickinson and Company
Aug 8, 2025
Maintains: Neutral
Price Target: $185$200
Current: $184.21
Upside: +8.57%
Masimo
Aug 6, 2025
Maintains: Overweight
Price Target: $200$210
Current: $146.41
Upside: +43.43%
Envista Holdings
Aug 1, 2025
Maintains: Neutral
Price Target: $17$19
Current: $20.06
Upside: -5.28%
Merit Medical Systems
Jul 31, 2025
Maintains: Overweight
Price Target: $110$105
Current: $82.75
Upside: +26.89%
Align Technology
Jul 31, 2025
Maintains: Overweight
Price Target: $250$190
Current: $133.14
Upside: +42.71%
Pulmonx
Jul 31, 2025
Downgrades: Neutral
Price Target: $9$2.5
Current: $1.98
Upside: +26.26%
NovoCure
Jun 27, 2025
Reiterates: Overweight
Price Target: $34
Current: $13.37
Upside: +154.30%
Maintains: Neutral
Price Target: $4.5$3.5
Current: $4.01
Upside: -12.72%
Maintains: Neutral
Price Target: $20$16
Current: $13.07
Upside: +22.42%
Maintains: Overweight
Price Target: $83$77
Current: $63.21
Upside: +21.82%
Maintains: Neutral
Price Target: $15$13
Current: $16.57
Upside: -21.54%
Maintains: Overweight
Price Target: $5$4.5
Current: $1.81
Upside: +148.62%
Maintains: Overweight
Price Target: $260$265
Current: $241.20
Upside: +9.87%
Maintains: Overweight
Price Target: $8$6
Current: $5.00
Upside: +20.00%
Reiterates: Overweight
Price Target: $7
Current: $4.19
Upside: +67.06%
Maintains: Overweight
Price Target: $70$20
Current: $2.10
Upside: +852.38%
Maintains: Outperform
Price Target: $310$372
Current: $545.39
Upside: -31.79%
Initiates: Overweight
Price Target: $95
Current: $79.40
Upside: +19.65%